Cutler Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,000
| Closed | -$413K | – | 5645 |
|
|
2022
Q3 | $413K | Sell |
8,000
-2,660
| -25% | -$110K | 0.03% | 619 |
|
|
2022
Q2 | $264K | Sell |
10,660
-14,675
| -58% | -$323K | 0.02% | 844 |
|
|
2022
Q1 | $635K | Buy |
25,335
+19,635
| +344% | +$552K | 0.03% | 582 |
|
|
2021
Q4 | $207K | Sell |
5,700
-2,465
| -30% | -$86.5K | 0.01% | 1286 |
|
|
2021
Q3 | $139K | Sell |
8,165
-30,398
| -79% | -$474K | 0.01% | 1645 |
|
|
2021
Q2 | $516K | Buy |
38,563
+35,783
| +1,287% | +$882K | 0.02% | 739 |
|
|
2021
Q1 | $142K | Buy |
2,780
+718
| +35% | +$43.2K | 0.01% | 1506 |
|
|
2020
Q4 | $127K | Sell |
2,062
-2,251
| -52% | -$129K | 0.01% | 1382 |
|
|
2020
Q3 | $236K | Buy |
4,313
+3,293
| +323% | +$177K | 0.01% | 846 |
|
|
2020
Q2 | $58K | Sell |
1,020
-280
| -22% | -$15.2K | ﹤0.01% | 1647 |
|
|
2020
Q1 | $52K | Sell |
1,300
-5,500
| -81% | -$234K | ﹤0.01% | 1703 |
|
|
2019
Q4 | $268K | Buy |
6,800
+1,600
| +31% | +$28.1K | 0.02% | 686 |
|
|
2019
Q3 | $35K | Buy |
5,200
+5,000
| +2,500% | +$37.5K | ﹤0.01% | 1798 |
|
|
2019
Q2 | $1K | Buy |
+200
| New | +$2.31K | ﹤0.01% | 4080 |
|
|
2018
Q1 | – | Sell |
-369
| Closed | -$2K | – | 5502 |
|
|
2017
Q4 | $2K | Sell |
369
-63
| -15% | -$432 | ﹤0.01% | 4273 |
|
|
2017
Q3 | $3K | Buy |
432
+350
| +427% | +$2.91K | ﹤0.01% | 4915 |
|
|
2017
Q2 | $0 | Sell |
82
-900
| -92% | -$6.61K | ﹤0.01% | 7338 |
|
|
2017
Q1 | $7K | Sell |
982
-833
| -46% | -$6K | ﹤0.01% | 4453 |
|
|
2016
Q4 | $13K | Buy |
1,815
+515
| +40% | +$3.71K | ﹤0.01% | 3939 |
|
|
2016
Q3 | $7K | Buy |
1,300
+900
| +225% | +$4.25K | ﹤0.01% | 4669 |
|
|
2016
Q2 | $1K | Sell |
400
-900
| -69% | -$3.38K | ﹤0.01% | 6372 |
|
|
2016
Q1 | $3K | Sell |
1,300
-7,291
| -85% | -$26.6K | ﹤0.01% | 5385 |
|
|
2015
Q4 | $69K | Buy |
+8,591
| New | +$60.8K | ﹤0.01% | 2130 |
|
Other funds holding CCXI
Cutler Group's CCXI Position: Q4 2022 in Review
Cutler Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 8,000 shares — an estimated $413K sold.
Cutler Group first reported a position in CCXI in Q4 2015 and held it in 23 quarters. The position peaked at $635K in Q1 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Cutler Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Cutler Group sold 8,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $413K.
- Cutler Group first reported a position in ChemoCentryx, Inc. in Q4 2015 and held it in 23 quarters.
- Cutler Group's ChemoCentryx, Inc. position peaked at $635K in Q1 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.